Dashboard
1
Company has very low debt and has enough cash to service the debt requirements
- DEBT-EQUITY RATIO (HY) Highest at -17.52 %
- DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
- DEBTORS TURNOVER RATIO(HY) Lowest at 6.99%
2
With ROE of 11.35%, it has a Fair valuation with a 1.74 Price to Book Value
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.39%
0%
14.39%
6 Months
13.55%
0%
13.55%
1 Year
13.76%
0%
13.76%
2 Years
10.71%
0%
10.71%
3 Years
77.14%
0%
77.14%
4 Years
-26.19%
0%
-26.19%
5 Years
-50.24%
0%
-50.24%
Shanghai INT Medical Instruments Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.51%
EBIT Growth (5y)
13.10%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.38
Tax Ratio
10.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.07%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.74
EV to EBIT
14.33
EV to EBITDA
10.07
EV to Capital Employed
1.91
EV to Sales
3.18
PEG Ratio
0.54
Dividend Yield
NA
ROCE (Latest)
13.29%
ROE (Latest)
11.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
831.90
681.30
22.10%
Operating Profit (PBDIT) excl Other Income
212.80
172.50
23.36%
Interest
3.50
1.00
250.00%
Exceptional Items
2.30
0.00
Consolidate Net Profit
169.30
155.60
8.80%
Operating Profit Margin (Excl OI)
192.60%
189.90%
0.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 22.10% vs 21.66% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 8.80% vs -8.09% in Dec 2022
About Shanghai INT Medical Instruments Co., Ltd. 
Shanghai INT Medical Instruments Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






